| Self-perception of knowledge and adherence reflecting the effectiveness of antiretroviral therapy C Dagli-Hernandez, RC Lucchetta, TR de Nadai, JCF Galduróz, ... Patient Preference and Adherence, 1787-1793, 2016 | 35 | 2016 |
| Population-scale predictions of DPD and TPMT phenotypes using a quantitative pharmacogene-specific ensemble classifier Y Zhou, C Dagli Hernandez, VM Lauschke British Journal of Cancer 123 (12), 1782-1789, 2020 | 32 | 2020 |
| Confounding variables and the performance of triggers in detecting unreported adverse drug reactions FR Varallo, C Dagli-Hernandez, C Pagotto, TR de Nadai, MT Herdeiro, ... Clinical Therapeutics 39 (4), 686-696, 2017 | 27 | 2017 |
| Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): A study protocol JB Borges, VF de Oliveira, GM Ferreira, B Los, TKAA Barbosa, ... Research in social and administrative pharmacy 17 (7), 1347-1355, 2021 | 23 | 2021 |
| Pharmacogenomics of statins: lipid response and other outcomes in Brazilian cohorts C Dagli-Hernandez, Y Zhou, VM Lauschke, FDV Genvigir, TDC Hirata, ... Pharmacological Reports 74 (1), 47-66, 2022 | 16 | 2022 |
| Late response to rosuvastatin and statin-related myalgia due to SLCO1B1, SLCO1B3, ABCB11, and CYP3A5 variants in a patient with Familial Hypercholesterolemia: a case report C Dagli-Hernandez, RCC de Freitas, ESR Marçal, RM Gonçalves, ... Annals of Translational Medicine 9 (1), 2021 | 11 | 2021 |
| LDLR missense variants disturb structural conformation and LDLR activity in T-lymphocytes of familial hypercholesterolemia patients TKA Barbosa, RDC Hirata, GM Ferreira, JB Borges, VF de Oliveira, ... Gene 853, 147084, 2023 | 8 | 2023 |
| Functional analysis of PCSK9 3′UTR variants and mRNA–miRNA interactions in patients with familial hypercholesterolemia B Los, JB Borges, VF Oliveira, RCC Freitas, C Dagli-Hernandez, ... Epigenomics 13 (10), 779-791, 2021 | 7 | 2021 |
| Cardiovascular pharmacogenomics: an update on clinical studies of antithrombotic drugs in Brazilian patients TDC Hirata, C Dagli-Hernandez, FDV Genvigir, VM Lauschke, Y Zhou, ... Molecular Diagnosis & Therapy 25 (6), 735-755, 2021 | 6 | 2021 |
| Genetic Variant ABCC1 rs45511401 Is Associated with Increased Response to Statins in Patients with Familial Hypercholesterolemia C Dagli-Hernandez, JB Borges, ESR Marçal, RCC de Freitas, AA Mori, ... Pharmaceutics 14 (5), 944, 2022 | 5 | 2022 |
| Effects of PCSK9 missense variants on molecular conformation and biological activity in transfected HEK293FT cells B Los, GM Ferreira, JB Borges, T Kronenberger, VF de Oliveira, ... Gene 851, 146979, 2023 | 3 | 2023 |
| In silico analysis of upstream variants in Brazilian patients with Familial hypercholesterolemia JNG de Araújo, VF de Oliveira, JB Borges, C Dagli-Hernandez, ... Gene 849, 146908, 2023 | 2 | 2023 |
| LDLR and PCSK9 3´UTR variants and their putative effects on microRNA molecular interactions in familial hypercholesterolemia: a computational approach RCC de Freitas, RH Bortolin, JB Borges, VF de Oliveira, ... Molecular Biology Reports 50 (11), 9165-9177, 2023 | 1 | 2023 |
| Identification of pathogenic variants in the Brazilian cohort with Familial hypercholesterolemia using exon-targeted gene sequencing JB Borges, VF Oliveira, C Dagli-Hernandez, GM Ferreira, TKAA Barbosa, ... Gene 875, 147501, 2023 | 1 | 2023 |
| Pharmacogenomics of Antihypertensive Drugs in Brazil: Recent Progress and Clinical Implications FD Vecchia Genvigir, C Dagli-Hernandez, TDC Hirata, Y Zhou, ... Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2022 | 1 | 2022 |
| Increased expression of miR-320b in blood plasma of patients in response to SARS-CoV-2 infection A de Souza Nicoletti, M Berlofa Visacri, ... Scientific Reports 14 (1), 13702, 2024 | | 2024 |
| Single-Nucleotide Polymorphisms Related to Vitamin D Metabolism and Severity or Mortality of COVID-19: A Systematic Review and Meta-analysis MB Visacri, JT Siguemoto, CM Neri, MCL de Abreu, A de Souza Nicoletti, ... Gene, 148236, 2024 | | 2024 |
| Predicted deleterious variants in ABCA1, LPL, LPA and KIF6 are associated with statin response and adverse events in patients with familial hypercholesterolemia and disturb … C Dagli-Hernandez, GM Ferreira, RCC de Freitas, JB Borges, ... Pharmacogenetics and Genomics, 10.1097, 2024 | | 2024 |
| Lipidomic analysis identified potential predictive biomarkers of statin response in subjects with Familial hypercholesterolemia A Cerda, RH Bortolin, MY Yoshinaga, RCC de Freitas, ... Chemistry and Physics of Lipids 257, 105348, 2023 | | 2023 |
| Pharmacogenomic analysis in patients with familial hypercholesterolemia CD Hernandez Universidade de São Paulo, 2022 | | 2022 |
